Post-mortem SNP analysis of CYP2D6 gene reveals correlation between genotype and opioid drug (tramadol) metabolite ratios in blood
Authors:
- Anna KoskiAKAnna Koski
- Ilkka OjanperäIOIlkka Ojanperä
- Erkki VuoriEVErkki Vuori
- Antti SajantilaASAntti Sajantila
- 1 July 2003
- journal article
- Published by Elsevier in Forensic Science International
- Vol. 135 (1) , 9-15
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Molecular Basis of Ethnic Differences in Drug Disposition and ResponseAnnual Review of Pharmacology and Toxicology, 2001
- Pharmacogenomics: Translating Functional Genomics into Rational TherapeuticsScience, 1999
- Polymorphic human cytochrome P450 enzymes: an opportunity for individualized drug treatmentTrends in Pharmacological Sciences, 1999
- MOLECULAR MECHANISMS OF GENETIC POLYMORPHISMS OF DRUG METABOLISMAnnual Review of Pharmacology and Toxicology, 1997
- Rapid detection of CYP2D6 null alleles by long distance-and multiplex-polymerase chain reactionPharmacogenetics, 1996
- Ultrarapid metabolizers of debrisoquine: Characterization and PCR‐based detection of alleles with duplication of the CYP2D6 geneFEBS Letters, 1996
- Characterization and PCR-based detection of two different hybrid CYP2D7P/CYP2D6 alleles associated with the poor metabolizer phenotype??Pharmacogenetics, 1996
- PCR-based genotyping for duplicated and deleted CYP2D6 genesPharmacogenetics, 1996
- Nomenclature for human CYP2D6 allelesPharmacogenetics, 1996
- Detection of the poor metabolizer-associated CYP2D6(D) gene deletion allele by long-PCR technologyPharmacogenetics, 1995